Events
Rural Minnesota Lung Cancer Summit, A Multidisciplinary Event for Providers
June 6 @ 8:00 am - 1:00 pm CDT
This summit is a multidisciplinary event dedicated to improving lung cancer diagnosis and treatment. Designed for healthcare providers, this summit offers the latest insights into lung screening, biomarker testing and the use of tissue and liquid biopsies.
Agenda & Speakers – Three 90-minute sessions plus optional networking breakfast & lunch
7 – 8 a.m. – Breakfast and networking (optional)
8 – 9:30 a.m. – Session 1: Overcoming Admin Barriers to Biomarker Testing/ US Guidelines/The How and Why of Biomarker Testing. Tabletop discussion to follow.
-
- Michael Koroscik, MBA, MHA, System Vice President of Oncology,
- Ying-Chun Lo, MD, PhD, Assistant Professor, Pathologist, Mayo Clinic
9:30 – 11 a.m. – Session 2: Overcoming Workflow and System Barriers to Increase Biomarker Testing
Panel moderated by Wade Swenson, MD, MPH, MBA, FACP, FACHE, Heartland Health.
Panel guests:
-
- Jenni Dyrdahl, Stage 4 lung cancer patient – a success story, thanks to biomarker testing and targeted therapy
- Corinne Kompelien, Oncology Nurse Navigator, Genomics, Sanford Cancer Center
- Joe Leach, MD, Medical Oncologist, Associate Medical Director, Quality and Safety. Allina Health Cancer Institute
- Manish Patel, DO, Medical Oncologist, Associate Professor of Medicine, University of Minnesota Medical School
- Robert Kratzke, MD, Medical Oncologist, Professor of Medicine, Section Head, Medical Oncology. University of Minnesota Medical School
- Josh Pritchett, MD, Assistant Professor of Medicine & Oncology, Rural Cancer Institute Advisor, Mayo Clinic
- Bret Friday, MD, PhD, Medical Director of Oncology Research, Essentia Health
11 a.m. – 12:30 p.m. – Session 3: Successful Screening Programs in MN – A Systematic Approach to IDing and Screening Eligible Patients for Lung Cancer (Pulmonology & Rural Primary Care). Q & A to follow.
Speakers:
-
- Anuja Sharma, MD, Allina Health, Twin Cities and outstate – 10,000 lung screenings in one year (system wide initiative at Allina involving PC)
- Abbie Begnaud, MD, Associate Professor of Medicine, University of Minnesota
- Timothy Pehl, MD, Grand Itasca Clinic and Hospital, Fairview, Grand Rapids, MN – PC partnership and intervention to bring screening to outstate patients
- Nils Arvold, MD, Radiation Oncologist, Chief, Section of Oncology/Radiation Oncology, Aspirus St. Luke’s Regional Cancer Center, Medical Director, Whiteside Institute for Clinical Research, University of Minnesota Medical School, Duluth
12:30 – 1 p.m. – Lunch and networking (optional)
VIEW EXHIBITOR BENEFITS
PROVIDERS: REGISTER BELOW TO HOLD YOUR SPOT
THANK YOU EXHIBITORS!
ASSOCIATE ($10,000)
CONTRIBUTORS ($5,000)
Amgen
AstraZeneca
Guardant Health
Merck
PATRONS ($2,500)
Daiichi Sankyo
Johnson and Johnson
Takeda
Tempus
SPEAKERS
Wade Swenson, MD, MPH, MBA, FACP, FACHE, Heartland Health
Dr. Wade Swenson, MD, MPH, MBA, is a medical oncologist and hematologist dedicated to improving cancer care in underserved rural areas. He is the Medical Director at Lakewood Health System in Staples, Minnesota, and a professor at both the University of North Dakota and Texas Christian University. Dr. Swenson holds leadership roles in multiple medical organizations and is a Certified Professional in Patient Safety. He founded the Rural Cancer Institute to address rural cancer care disparities, with his research published in top medical journals. Outside work, he enjoys outdoor activities, travel, and exploring coffee shops and microbreweries.
Michael Koroscik, MBA, MHA, FACHE
Mike is the System Vice President at Main Line Health Cancer Care.
Mike has more than two decades of oncology leadership experience for both large health systems and physician groups including prior executive roles at Advocate Aurora, Allina Health and Sutter Health. Mike is passionate about developing and advancing lung cancer screening programs, including the current use of AI to advance early detection. Mike’s experience includes operations and strategy development inside comprehensive cancer programs.
Mike holds a Master’s degree from Northwestern University – Kellogg School of Management. Mike has presented and published articles on oncology trends in management including value and population health initiatives.
Ying-Chun Lo, MD, PhD, Assistant Professor, Pathologist, Mayo Clinic
Dr. Lo is an anatomic pathologist specialized in thoracic pathology and a molecular pathologist focusing on solid tumor molecular testing. He is currently a consultant at Mayo Clinic and assistant professor of Laboratory Medicine and Pathology at Mayo Clinic College of Medicine. Dr. Lo has active leadership roles as Vice Chair of Innocation and co-lead of Tissue Slide Review (TSR) area. He is currently a member of the pathology committee and respiratory committee of Alliance of Clinical Trials. Dr. Lo’s research interests focus on lung cancer, solid tumor molecular profiling, cancer immunotherapy, and biomarker testing.
Jenni Dyrdahl, Lung Cancer Patient
Joe Leach, MD, Allina Oncology, Twin Cities, MN
Dr. Leach of the Minnesota Health Fairview Cancer Center and Prime Therapeutics received his medical school training at the University of Minnesota and completed his fellowship at the University of Oklahoma College of Medicine. His specialties include: Benign Hematology, Hematologic Malignancy, Medical Oncology. Dr. Leach says the thing that he loves most about being an oncologist is the relationships he’s developed with his patients and their families over the years. He says there is something sacred about his job that he’ll never take for granted.
Manish Patel, DO, University of Minnesota Oncology, Twin Cities, MN
Dr. Patel studied at Kirksville College of Osteopathic Medicine, receiving a Doctor of Osteopathy degree in 2001. Dr. Patel then pursued residency in Internal Medicine at McGaw Medical Center of Northwestern University and completed a clinical research fellowship at Winthrop University Hospital. In 2006 he joined the Hematology, Oncology and Transplantation fellowship at the University of Minnesota and in July 2010 became a faculty member of the Division. In 2019, Dr. Patel became the associate program director for the hematology, oncology, and transplantation fellowship program. He also leads the experimental therapeutics phase I clinical program at the University of Minnesota.
Josh Pritchett, MD, Mayo Clinic, Rochester, MN, Oncology/Assistant Professor of Medicine/Oncology, Rural Medicine Institute
Dr. Pritchett, a Cloquet, MN native and University of Minnesota Medical School graduate, is an Assistant Professor of Medicine and Oncology at Mayo Clinic. He holds dual appointments in Rochester, MN, and La Crosse, WI, focusing on innovation in community-based cancer care. His research aims to improve access for rural cancer patients through innovative care models. A recipient of multiple awards, he helped develop Mayo Clinic’s “DEFeNDR” remote patient monitoring program and co-leads the Stanford-Mayo Telehealth in Cancer Collaborative. He also serves as an advisor with the Rural Cancer Institute.
Bret Friday, MD, PhD, Essentia Health, Medical Director of Oncology Research, Duluth, MN
Bret Friday, MD is a hematologist/oncologist at Essentia Health in Duluth and Virginia, MN and has over 20 years of experience in the medical field. He graduated from Emory University in 2002.
Anuja Sharma, MD, Allina Health, Twin Cities and outstate – 10,000 lung screenings in one year (system wide initiative at Allina involving PC)
Dr. Sharma is a pulmonologist, critical care specialist, and sleep medicine expert with extensive experience in clinical practice, leadership, and research. He currently serves as Co-Chair of the Allina Health Thoracic Oncology Committee and Medical Director of the Early Lung Cancer Detection Program. Previously, he was President of Pulmonary and Critical Care Associates and Medical Director of multiple sleep centers. He has contributed to pioneering lung cancer screening initiatives and holds board certifications in Pulmonary, Critical Care, Sleep, and Interventional Pulmonary Medicine. Dr. Sharma has presented internationally, published extensively, and remains active in committee leadership and community advocacy.
Abbie Begnaud, MD, University of Minnesota
Timothy Pehl, MD, Grand Itasca Clinic and Hospital, Fairview, Grand Rapids, MN – PC partnership and intervention to bring screening to outstate patients
Robrt Kratzke, MD, Professor of Medicine, University of Minnesota, Twin Cities, MN
Nills Arvold, MD, Radiation Oncologist, Aspirus St. Lukes, Duluth, MN
Dr. Arvold is a radiation oncologist at Aspirus St. Luke’s in Duluth, MN, and the Medical Director of the Whiteside Institute for Clinical Research at the University of Minnesota Medical School, Duluth. He attended Harvard Medical School and was an Assistant Professor at Brigham & Women’s/Dana-Farber Cancer Institute before returning to his hometown. His research interests include outcomes of rural patients undergoing low-dose CT lung cancer screening, and the use of IT to better identify patients eligible for screening.